# Psyence Labs Ltd.

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/psyence-labs-ltd
Canonical HTML page: https://gethealthbrief.com/entity/psyence-labs-ltd

## Timeline

- **2026-03-15**: Valuation Period — Expected timeframe for determining the fair market value of the equity investment.
- **2026-02-20**: Option Exercised — PsyLabs officially triggers the put option, requiring an equity investment from PBM.
- **2025-01-01**: Put Option Established — Psyence BioMed and PsyLabs enter into a strategic put option agreement.

## Recent coverage (1 stories)

### Psyence BioMed Strengthens Supply Chain with Strategic PsyLabs Investment
2026-02-21 00:39:13 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Psyence Biomedical Ltd. (Nasdaq: PBM) has confirmed a strategic equity investment in PsyLabs following the exercise of a previously established put option. This move deepens the integration between the biopharmaceutical developer and its primary manufacturer of pharmaceutical-grade psychedelic compounds.
Full story: https://gethealthbrief.com/story/psyence-biomed-psylabs-equity-investment-put-option

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.